| Datum |
Zeit |
Quelle |
Überschrift |
|---|
| 10.4.2024 | 14:05 | GLOBE | MaxCyte to Report First Quarter 2024 Financial Results on.. |
| 10.4.2024 | 14:05 | UK RNS | MaxCyte, Inc. Notice of Results |
| 03.4.2024 | 08:00 | UK RNS | MaxCyte, Inc. Total Voting Rights and Block Listing Return |
| 02.4.2024 | 16:19 | ALNC |  TRADING UPDATES: MaxCyte inks deal with Be Bio; Orcadian.. |
| 02.4.2024 | 14:05 | UK RNS | MaxCyte, Inc. Signing of Strategic Platform License |
| 02.4.2024 | 14:05 | GLOBE | MaxCyte Signs Strategic Platform License with Be Biopharma.. |
| 02.4.2024 | 08:00 | UK RNS | MaxCyte, Inc. Exercise of options and PDMR dealing |
| 20.3.2024 | 11:16 | UK RNS | MaxCyte, Inc. Grant of Options, RSUs and PSUs and PDMR.. |
| 20.3.2024 | 11:05 | UK RNS | MaxCyte, Inc. Grant of Options, RSUs and PSUs and PDMR.. |
| 13.3.2024 | 12:54 | ALNC | IN BRIEF: MaxCyte loss widens in 2023 as core revenue.. |
| 13.3.2024 | 08:05 | UK RNS | MaxCyte, Inc. Filing of form 10-K for FY ended December 31,.. |
| 13.3.2024 | 08:00 | UK RNS | MaxCyte, Inc. Reports Q4 & FY 2023 Financial Results |
| 12.3.2024 | 21:05 | UKREG | MaxCyte Reports Fourth Quarter and Full Year 2023 Financial.. |
| 06.3.2024 | 09:58 | UK RNS | MaxCyte, Inc. TR-1: Notification of major holdings |
| 05.3.2024 | 21:43 | ALNC | EARNINGS: dotdigital eyes rosy future; Beeks Financial turns.. |
| 05.3.2024 | 08:00 | UK RNS | MaxCyte, Inc. Preliminary FY Results & 2024 Guidance |
| 04.3.2024 | 22:05 | UKREG | MaxCyte Initiates Full Year 2024 Guidance and Reaffirms 2023.. |
| 01.3.2024 | 18:57 | UK RNS | MaxCyte, Inc. Total Voting Rights |
| 29.2.2024 | 10:21 | UK RNS | MaxCyte, Inc. Exercise of options and PDMR dealing |
| 26.2.2024 | 08:00 | UK RNS | MaxCyte, Inc. TR-1: Notification of major holdings |
| 09.2.2024 | 14:05 | UK RNS | MaxCyte, Inc. Notice of Results |
| 09.2.2024 | 14:05 | UKREG | MaxCyte to Report Fourth Quarter and Full Year 2023.. |
| 01.2.2024 | 10:24 | UK RNS | MaxCyte, Inc. Total Voting Rights |
| 31.1.2024 | 08:00 | UK RNS | MaxCyte, Inc. Director/PDMR Shareholding |
| 30.1.2024 | 15:29 | UK RNS | MaxCyte, Inc. Holding(s) in Company |
| 30.1.2024 | 14:58 | ALNC | IN BRIEF: MaxCyte signs licencing deal with cell therapy.. |
| 30.1.2024 | 14:05 | UK RNS | MaxCyte, Inc. Signing of Strategic Platform License |
| 30.1.2024 | 14:05 | UKREG | MaxCyte and Wugen Sign Strategic Platform License to.. |
| 29.1.2024 | 18:56 | ALNC | IN BRIEF: MaxCyte chief scientific officer leaves firm |
| 29.1.2024 | 17:52 | UK RNS | MaxCyte, Inc. TR-1: Notification of major holdings |
| 29.1.2024 | 08:00 | UK RNS | MaxCyte, Inc. Filing of Form 8-K |
| 23.1.2024 | 19:39 | ALNC | TRADING UPDATES: Esken's Southend Airport faces further.. |
| 23.1.2024 | 14:05 | UKREG | MaxCyte, Inc. Signing of Strategic Platform License |
| 23.1.2024 | 14:05 | GLOBE | MaxCyte Signs Strategic Platform License with Imugene to.. |
| 09.1.2024 | 13:18 | ALNC | MaxCyte's strategic platform licences redeem otherwise.. |
| 09.1.2024 | 08:00 | UKREG | MaxCyte, Inc. Preliminary Unaudited Q4 and FY 2023 Results |
| 08.1.2024 | 22:05 | GLOBE | MaxCyte Announces Preliminary Unaudited Fourth Quarter and.. |
| 05.1.2024 | 08:00 | UKREG | MaxCyte, Inc. Grant of Options and PDMR Dealing |
| 03.1.2024 | 15:04 | ALNC | MaxCyte teams with Singapore-based Lion to support TCR-T.. |
| 03.1.2024 | 14:05 | GLOBE | MaxCyte and Lion TCR form Partnership to Support Global.. |
| 03.1.2024 | 14:05 | UKREG | MaxCyte, Inc. Signing of Strategic Platform License |
| 02.1.2024 | 10:23 | UKREG | MaxCyte, Inc. Total Voting Rights |
| 02.1.2024 | 08:00 | GLOBE | MaxCyte Confirms Appointment of Maher Masoud as President,.. |
| 02.1.2024 | 08:00 | UKREG | MaxCyte, Inc. Confirmation of Board change |
| 29.12.2023 | 08:00 | UKREG | MaxCyte, Inc. Exercise of options and PDMR dealing |
| 12.12.2023 | 16:56 | ALNC | TRADING UPDATES: Technology Minerals identifies lithium at.. |
| 12.12.2023 | 08:00 | UKREG | MaxCyte, Inc. CEO Transition and Revenue Guidance Update |
| 11.12.2023 | 22:05 | GLOBE | MaxCyte Announces CEO Transition and Updates Revenue.. |
| 07.12.2023 | 10:50 | UKREG | MaxCyte, Inc. Exercise of options and PDMR dealing |
| 04.12.2023 | 08:00 | UKREG | MaxCyte, Inc. Exercise of options and PDMR dealing |
Hot Features
Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Premium
